Concepedia

Publication | Open Access

Phase II Multicenter Trial of Voreloxin as Second-Line Therapy in Chemotherapy-Sensitive or Refractory Small Cell Lung Cancer

DOIFull Paper Access

20

Citations

9

References

2011

Year

Lee M. Krug, Jeffrey Crawford, David S. Ettinger, Geoffrey I. Shapiro, David R. Spigel, Tony Reiman, Jennifer S. Temel, Glenn Michelson, Donald Y. Young, Ute Hoch,
Journal of Thoracic Oncology

References

YearCitations

Page 1